KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Clover Health Investments (CLOV) Equity Ratio (2019 - 2025)

Clover Health Investments' Equity Ratio history spans 7 years, with the latest figure at 0.57 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 2.86% year-over-year to 0.57; the TTM value through Dec 2025 reached 0.57, down 2.86%, while the annual FY2025 figure was 0.57, 2.86% down from the prior year.
  • Equity Ratio reached 0.57 in Q4 2025 per CLOV's latest filing, down from 0.61 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 1.01 in Q4 2022 to a low of 0.18 in Q1 2022.
  • Average Equity Ratio over 5 years is 0.53, with a median of 0.57 recorded in 2021.
  • Peak YoY movement for Equity Ratio: surged 173.5% in 2021, then tumbled 73.07% in 2022.
  • A 5-year view of Equity Ratio shows it stood at 0.57 in 2021, then soared by 77.12% to 1.01 in 2022, then plummeted by 50.12% to 0.5 in 2023, then rose by 17.05% to 0.59 in 2024, then fell by 2.86% to 0.57 in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Equity Ratio are 0.57 (Q4 2025), 0.61 (Q3 2025), and 0.6 (Q2 2025).